More about GlaxoSmithKline Pharmaceuticals Limited

Technicals for GlaxoSmithKline Pharmaceuticals Limited

The current state of the STOCHASTIC is neutral for GLAXO, providing no...

GLAXO's forward EPS surpassing its trailing EPS signals that the company is...

The list of all important regulatory filings for GlaxoSmithKline Pharmaceuticals Limited which...

This article explores the detrimental effects of terrorism on India's economy, highlighting...

The proactive measures taken by Indian airlines in response to the Pahalgam...

This article examines the stock market volatility and investor behavior in India...

Last Updated:

2025-04-25 21:08

Published	Title	Summary
2025-01-20 15:40:54	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 14-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2025-01-15 12:39:50	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 10-Feb-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 .
2024-07-22 13:05:12	Board Meeting Intimation	GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting...
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be held on 02-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 .
2024-05-17 14:11:26	Record Date	GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date...
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange that Record date for the purpose of Dividend is 31-May-2024.